Search Results - "Bartneck, M"

Growth factor-functionalized silk membranes support wound healing in vitro by Bienert, Michaela, Hoss, M, Bartneck, M, Weinandy, S, Böbel, M, Jockenhövel, S, Knüchel, R, Pottbacker, K, Wöltje, M, Jahnen-Dechent, W, Neuss, S

“…Chronic wounds represent a serious problem in daily medical routine requiring improved wound care. Silk of the domesticated silkworm (Bombyx mori) has been…”
Get more information

Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short‐term mortality by Zimmermann, H. W., Reuken, P. A., Koch, A., Bartneck, M., Adams, D. H., Trautwein, C., Stallmach, A., Tacke, F., Bruns, T.

“…Objective Patients with decompensated cirrhosis are susceptible to bacterial infections, which are associated with organ failure and a high mortality rate…”
Get full text

CCL2-dependent monocyte recruitment contributes to a tumor-promoting microenvironment in a combined fibrosis-HCC model by Schrammen, P.L, Bartneck, M, Möckel, D, Liepelt, A, Eulberg, D, Longerich, T, Lüdde, T, Trautwein, C, Lammers, T, Tacke, F

Get full text

P0448 : Benefits of isolating HSC using fluorescence-based cell sorting by Bartneck, M, Warzecha, K.T, Tag, C.G, Sauer-Lehnen, S, Heymann, F, Trautwein, C, Weiskirchen, R, Tacke, F

Get full text

1105 PHARMACOLOGICAL INHIBITION OF CCL2 LIMITS ANGIOGENESIS ASSOCIATED WITH CHRONIC TOXIC LIVER INJURY IN VIVO BY RESTRAINING INFILTRATION OF PROANGIOGENIC INFLAMMATORY MONOCYTES by Bartneck, M, Ehling, J, Wei, X, Fech, V, Gassler, N, Eulberg, D, Trautwein, C, Lammers, T, Tacke, F

Get full text

1027 COMPARTMENTAL REGULATION OF suPAR IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: EVALUATION OF ORIGIN, REGULATION AND PROGNOSTIC RELEVANCE by Zimmermann, H.W, Reuken, P.A, Koch, A, Bartneck, M, Adams, D.H, Trautwein, C, Stallmach, A, Tacke, F, Bruns, T

Get full text

P594 PROMOTION OF LIVER INJURY AND FIBROSIS BY THE LIVER-DERIVED PLASMA PROTEIN HISTIDINE-RICH GLYCOPROTEIN IS BASED ON POLARIZING HEPATIC MACROPHAGES TOWARDS THE INFLAMMATORY M1 PHENOTYPE by Bartneck, M, Fech, V, Ehling, J, Wei, X, Warzecha, K, Hittatiya, K, Gassler, N, Lammers, T, Jahnen-Dechent, W, Trautwein, C, Tacke, F

Get full text

360 EFFECTS OF NANOROD-CONJUGATED PEPTIDES FOR CELL TARGETING OF HEPATIC MACROPHAGES IN ACUTE AND CHRONIC MURINE LIVER INJURY by Bartneck, M, Ritz, T, Keul, H.A, Wambach, M, Bornemann, J, Gbureck, U, Gassler, N, Groll, J, Trautwein, C, Tacke, F

Get full text

P0493 : Selectin-targeting nanoparticles for immunomodulatory therapy of liver diseases by Bartneck, M, Schlößer, C.T, Warzecha, K.T, Lammers, T, Trautwein, C, Moog, K, Kunz, H, Zentel, R, Barz, M, Tacke, F

Get full text

MicroRNA-26b as novel regulator of cardio-metabolic diseases by Van Der Vorst, E, Rakateli, L, Peters, L, Bidzhekov, K, Jans, A, Maas, S, Gijbels, M, Jankowski, J, Biessen, E, Weber, C, Doering, Y, Bartneck, M

“…Abstract Funding Acknowledgements  Type of funding sources: Public grant(s) – National budget only. Main funding source(s): IZKF Increasing evidence has shown…”
Get full text

Microrna-26B as novel regulator of cardio-metabolic diseases by Peters, L., Bidzhekov, K., Rakateli, L., Jans, A., Maas, S., Gijbels, M., Jankowski, J., Döring, Y., Biessen, E., Houben, T., Bartneck, M., Van Der Vorst, E.

Get full text

Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b by Marquez, A. Bonnin, Peters, L., Stolberg, R., Fluonia, Z., Bouma, J., Sundararaman, S.S., Maas, S., Lin, C., Jans, A., Muñoz-Castañeda, J.R., Wong, D., Boor, P., Bidzhekov, K., Bartneck, M., Weber, C., Jankowski, J., Biessen, E., Van Der Vorst, E.

Get full text

OR4-3TARGETING LIVER INFLAMMATION USING MINCLE-TARGETED LIPOSOMES AS A NOVEL DRUG DELIVERY SYSTEM by Szachniewicz, M, Bartneck, M, Tacke, F, Bansal, R

Get full text

Micromanaging atherosclerosis: myeloid cell-specific microRNA-26b attenuates atherosclerosis development by Peters, L, Bidzhekov, K, Jansen, Y, Bayasgalan, S, Gencer, S, Sundararaman, SS, Bonnin-Marquez, A, Yan, Y, Jans, AM, Bartneck, M, Doering, Y, Weber, C, Van Der Vorst, E

“…Abstract Funding Acknowledgements Type of funding sources: None. Increasing evidence has shown that microRNAs (miRs) are fundamental players in…”
Get full text

Micromanaging atherosclerosis: Myeloid cell-specific microRNA-26b attenuates atherosclerosis development by Peters, L., Bidzhekov, K., Jansen, Y., Bayasgalan, S., Gencer, S., Sundararaman, S.S., Bonnin-Marquez, A., Yan, Y., Jans, A.M., Bartneck, M., Doering, Y., Weber, C., Van Der Vorst, E.

Get full text

SAT-126 - CCL2-dependent monocyte recruitment contributes to a tumor-promoting microenvironment in a combined fibrosis-HCC model by Schrammen, P.L., Bartneck, M., Möckel, D., Liepelt, A., Eulberg, D., Longerich, T., Lüdde, T., Trautwein, C., Lammers, T., Tacke, F.

Get full text

Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface by Paul, Nora E, Skazik, Claudia, Harwardt, Marc, Bartneck, Matthias, Denecke, Bernd, Klee, Doris, Salber, Jochen, Zwadlo-Klarwasser, Gabriele

“…Abstract In this study we investigated the influence of surface topography on the inflammatory response of human macrophages. We generated different…”
Get full text

Visualization of remodeling of the extracellular matrix in the MCP-Knockout mouse in chronic myocardial infarction with an elastin-binding contrast agent by Butzbach, B., Protti, A., Dong, X., Tacke, F., Bartneck, M., Onthank, D., Nagel, E., Shah, A., Kelm, M., Botnar, R.

Get full text